Cory T. Bernadt, Ph.D.
Affiliations: | 2004 | University of Nebraska Medical Center, Omaha, NE, United States |
Area:
Molecular Biology, Cell Biology, OncologyGoogle:
"Cory Bernadt"Mean distance: (not calculated yet)
Parents
Sign in to add mentorAngie Rizzino | grad student | 2004 | University of Nebraska Medical Center | |
(Mechanisms involved in the differential expression of the fibroblast growth factor-4 gene and the type II transforming growth factor-beta receptor gene in embryonal carcinoma cells and their differentiated counterparts.) |
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Weimholt RC, Sharifai N, Abro B, et al. (2019) Reactivity with the EpCAM-specific antibodies MOC-31 and Ber-Ep4 in plasma cell neoplasms: a potential diagnostic pitfall in cytology samples. Journal of the American Society of Cytopathology |
Bibbey SM, Collins BT, Bernadt CT. (2018) Fluorescence in situ hybridization of thyroid fine-needle aspiration biopsy distinguishes between neoplastic and non-neoplastic Hürthle cell lesions. Journal of the American Society of Cytopathology. 7: 195-200 |
Weimholt RC, Sharifai N, Vij K, et al. (2018) EpCAM Expression with the Antibodies MOC-31 and Ber-Ep4 in Plasma Cell Neoplasms: A Potential Diagnostic Pitfall in Serous Effusion Cytology Journal of the American Society of Cytopathology. 7: S1-S2 |
Jalaly JB, Lewis JS, Collins BT, et al. (2015) Correlation of p16 immunohistochemistry in FNA biopsies with corresponding tissue specimens in HPV-related squamous cell carcinomas of the oropharynx. Cancer Cytopathology |
Bernadt CT, Collins BT. (2015) Fine-needle aspiration biopsy of hürthle cell neoplasms of the thyroid Pathology Case Reviews. 20: 121-124 |
Collins BT, Wang JF, Bernadt CT. (2013) Utilization of p40 (ΔNp63) with p63 and cytokeratin 5/6 immunohistochemistry in non-small cell lung carcinoma fine-needle aspiration biopsy. Acta Cytologica. 57: 619-24 |
Boer B, Kopp J, Mallanna S, et al. (2007) Elevating the levels of Sox2 in embryonal carcinoma cells and embryonic stem cells inhibits the expression of Sox2:Oct-3/4 target genes. Nucleic Acids Research. 35: 1773-86 |
Boer B, Bernadt CT, Desler M, et al. (2006) Differential activity of the FGF-4 enhancer in F9 and P19 embryonal carcinoma cells. Journal of Cellular Physiology. 208: 97-108 |
Bernadt CT, Nowling T, Wiebe MS, et al. (2005) NF-Y behaves as a bifunctional transcription factor that can stimulate or repress the FGF-4 promoter in an enhancer-dependent manner. Gene Expression. 12: 193-212 |
Boer B, Luster TA, Bernadt C, et al. (2005) Distal enhancer of the mouse FGF-4 gene and its human counterpart exhibit differential activity: critical role of a GT box. Molecular Reproduction and Development. 71: 263-74 |